Copyright 1998 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1998
In reviewing the article by Herndon et al,1 published in the September 1997 issue of the ARCHIVES, I noticed what might be an error in the text. On page 1139, left column, first complete paragraph, last sentence, the following is stated: "The mean±SD CCT of the 46 eyes being treated with dorozolamide (0.551±0.020) was significantly greater than that of the 28 eyes not receiving dorzolamide (0.560±0.025) (P=.02)."
Hustead JD. Central Corneal Thickness. Arch Ophthalmol. 1998;116(9):1263. doi: